INTRODUCTION: Residual symptoms such as fatigue, cognitive limitations, and emotional distress can be experienced by cancer survivors. These symptoms may impact their abilities at work. It is unclear to what degree these symptoms are associated with work in occupationally active breast cancer survivors, the most prevalent cancer survivor group. METHODS: A sample of 100 women working part- or full-time with a history of breast cancer and a noncancer comparison group (n = 103) completed questionnaires related to physical fatigue, depression, anxiety, and cognitive limitations. Demographic variables, job stress, type of job, stage at diagnosis, treatment exposure, and health behaviors were also measured as potential confounders. RESULTS: Four years postdiagnosis breast cancer survivors reported higher levels of age-adjusted work limitations (F = 32.708, P < 0.001). Significant group by fatigue (beta = -0.311, 95% CI = -0.545 to -0.076) and group by depression (beta = 0.331, 95% CI = 0.024 to 0.638) interactions were observed. Fatigue was more strongly related to work limitations in the cancer survivor group whereas depressive symptoms were more strongly related to limitations at work in the noncancer group. Although fatigue accounted for 22% of the variance in the model, it explained 71% of the contribution of symptom burden to the overall model. CONCLUSIONS: Fatigue was more strongly related to work in the breast cancer survivor group after accounting for many potential confounders. There is a pressing need to better understand and effectively manage fatigue in the workplace in occupationally active breast cancer survivors.
INTRODUCTION: Residual symptoms such as fatigue, cognitive limitations, and emotional distress can be experienced by cancer survivors. These symptoms may impact their abilities at work. It is unclear to what degree these symptoms are associated with work in occupationally active breast cancer survivors, the most prevalent cancer survivor group. METHODS: A sample of 100 women working part- or full-time with a history of breast cancer and a noncancer comparison group (n = 103) completed questionnaires related to physical fatigue, depression, anxiety, and cognitive limitations. Demographic variables, job stress, type of job, stage at diagnosis, treatment exposure, and health behaviors were also measured as potential confounders. RESULTS: Four years postdiagnosis breast cancer survivors reported higher levels of age-adjusted work limitations (F = 32.708, P < 0.001). Significant group by fatigue (beta = -0.311, 95% CI = -0.545 to -0.076) and group by depression (beta = 0.331, 95% CI = 0.024 to 0.638) interactions were observed. Fatigue was more strongly related to work limitations in the cancer survivor group whereas depressive symptoms were more strongly related to limitations at work in the noncancer group. Although fatigue accounted for 22% of the variance in the model, it explained 71% of the contribution of symptom burden to the overall model. CONCLUSIONS:Fatigue was more strongly related to work in the breast cancer survivor group after accounting for many potential confounders. There is a pressing need to better understand and effectively manage fatigue in the workplace in occupationally active breast cancer survivors.
Authors: Amye J Tevaarwerk; Ju-Whei Lee; Abigail Terhaar; Mary E Sesto; Mary Lou Smith; Charles S Cleeland; Michael J Fisch Journal: Cancer Date: 2015-12-21 Impact factor: 6.860
Authors: Sietske J Tamminga; Jos H A M Verbeek; Monique H W Frings-Dresen; Angela G E M De Boer Journal: Qual Life Res Date: 2013-07-27 Impact factor: 4.147
Authors: Andy S K Cheng; Yingchun Zeng; Xiangyu Liu; Shaxin Liu; Stella W C Cheng; Cindy T T Kwok; Raymond C K Chung; Jianfei Xie; Michael Feuerstein Journal: J Cancer Surviv Date: 2018-09-18 Impact factor: 4.442
Authors: Reshma Jagsi; Sarah T Hawley; Paul Abrahamse; Yun Li; Nancy K Janz; Jennifer J Griggs; Cathy Bradley; John J Graff; Ann Hamilton; Steven J Katz Journal: Cancer Date: 2014-04-28 Impact factor: 6.860
Authors: Floortje K Ploos van Amstel; Sanne W van den Berg; Hanneke W M van Laarhoven; Marieke F M Gielissen; Judith B Prins; Petronella B Ottevanger Journal: Support Care Cancer Date: 2013-03-01 Impact factor: 3.603
Authors: Sietske J Tamminga; Angela G E M de Boer; Jos H A M Verbeek; Taina Taskila; Monique H W Frings-Dresen Journal: BMC Cancer Date: 2010-07-01 Impact factor: 4.430